GeminIQ Website Logo

Viewing TDAC free

Subscribe for full history, 90+ metrics, screener, watchlist...

Translational Development Acquisition Corp.

TDAC

Subscribe to unlock 17+ years of data

Financial Statements

Values in Millions ($)
2026-06-30
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Financial statements beyond 3 years are for subscribers only.

Unlock 17+ years of income statements, balance sheets, and cash flow statements

Start 7-day free trial
Subscriber-only column
Assets
Cash And Cash Equivalents At Carrying Value
0000000
Assets Current
Assets Current
0000001
Prepaid Expense Current
0000000
Assets Held In Trust Noncurrent
157183182180178176174
Assets
157183182180178177175
Liabilities And Stockhold…
Accounts Payable And Accrued Liabilities Current
0000000
Accounts Payable Current
------0
Liabilities Current
Liabilities Current
2110000
Other Liabilities Current
0000000
Notes Payable Current
1100---
Liabilities
8776666
Stockholders Equity
Retained Earnings Accumulated Deficit
-8-7-7-6-6-6-6
Stockholders Equity
-8-7-7-6-6-6-6
Liabilities And Stockholders Equity
157183182180178177175
Common Class A
-000000
Classa Ordinary Shares Subject To Redemption
-000-17170
Classa Ordinary Shares Not Subject To Redemption
-000000
Common Class B
-550055
Preferred Stock Par Or Stated Value Per Share
0000000
Preferred Stock Shares Authorized
1111111
Preferred Stock Shares Issued
0000000
Preferred Stock Shares Outstanding
0000000
Shares Outstanding
------0

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Custom Table

0/5
Search a metric to start building a table

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Interactive Financial Visualizations

0/1
Search a metric to start building a visual

Subscribe to unlock 17+ years of data

Earnings Market Reaction

Fiscal Year
Q1 1 Month
Q1 2 Month
Q1 3 Month
Q2 1 Month
Q2 2 Month
Q2 3 Month
Q3 1 Month
Q3 2 Month
Q3 3 Month
Q4 1 Month
Q4 2 Month
Q4 3 Month
20260.94%0.66%1.79%---------
20250.39%1.08%1.77%0.19%0.19%1.26%0.10%0.58%0.96%1.04%0.57%1.61%
2024---------0.40%1.59%1.88%

Earnings Market Reaction data beyond 3 years is for subscribers only.

Unlock the full earnings market reaction history

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics
2026-06-30
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Metric history beyond 3 years is for subscribers only.

Unlock 17+ years of history across 90+ calculated metrics

Start 7-day free trial
Subscriber-only column
Liquidity Ratios
Current Ratio
0.06
0.09
0.07
0.19
0.55
1.29
3.09
Quick Ratio
0.05
0.03
0.05
0.11
0.12
0.64
2.08
Working Capital
-1.65M
-785.77K
-504.61K
-342.26K
-128.61K
92.52K
439.93K
Leverage & Debt
Debt to Equity
-1.01
-1.01
-1.01
-1.01
-1.03
-1.07
-1.12
Debt Ratio
0.05
0.04
0.04
0.04
0.04
0.04
0.04
Efficiency & Turnover
Asset Turnover TTM
0.00
0.00
0.00
0.00
-
-
-
Per Share Metrics
Diluted EPS TTM
-
0.36
1.37
0.28
-
-
-
Free Cash Flow Per Share TTM
-
-0.04
-0.13
-0.02
-
-
-
Dividend Per Share TTM
-
0.00
0.00
0.00
-
-
-
Valuation Metrics
P/E TTM
-
29.38
7.68
37.46
-
-
-
P/B TTM
-
-26.75
-7.47
-27.98
-28.73
-29.25
-
Market Cap
-
182.50M
48.86M
178.54M
177.16M
173.88M
-
Enterprise Value
-
182.98M
49.03M
178.59M
177.12M
173.67M
-
Calculated Values
Free Cash Flow TTM
-775.80K
-681.97K
-608.39K
-259.45K
-
-
-
Net Debt
1.01M
475.37K
170.21K
52.85K
-35.26K
-206.60K
-438.17K
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of data

No insider data available.

Subscribe to unlock 17+ years of data

Institutional Ownership

No data available for chart
2026-03-31
91.98%
Inst. Shares: 15,866,121
Shares Outstanding: 17,250,000
2025-12-31
293.91%
Inst. Shares: 13,688,760
Shares Outstanding: 4,657,500
2025-09-30
82.14%
Inst. Shares: 14,168,540
Shares Outstanding: 17,250,000
2025-06-30
75.17%
Inst. Shares: 12,967,506
Shares Outstanding: 17,250,000
2025-03-31
61.13%
Inst. Shares: 10,545,006
Shares Outstanding: 17,250,000

Translational Development Acquisition Corp. (TDAC) — SEC Financial Statements & Analysis

Translational Development Acquisition Corp. (TDAC) is a blank checks company. Translational Development Acquisition Corp. trades on Nasdaq as: TDAC, TDACU, TDACW. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Translational Development Acquisition Corp. reported a Debt-to-Equity ratio of -1.01x, a Price-to-Book (P/B) ratio of -26.75x (TTM), at a market cap of $182.50M. Figures below are sourced from SEC EDGAR, as-filed.

Debt To Equity
-1.01x
P/B TTM
-26.75x
Market Cap
$182.50M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Translational Development Acquisition Corp. in?

Translational Development Acquisition Corp. (TDAC) operates in the Blank Checks industry.

What is TDAC's market cap?

Translational Development Acquisition Corp. (TDAC) has a market capitalization of $182.50M as of 2026-03-31.

What is TDAC's P/E ratio?

Translational Development Acquisition Corp. (TDAC)'s trailing twelve month P/E ratio is 29.38x as of 2026-03-31.

What exchange does TDAC trade on?

Translational Development Acquisition Corp. (TDAC) trades on the Nasdaq.

Wall Street's data.
Main Street's price.